Paradigm shift: Preliminary clinical categorization of ultrahigh risk for childhood bipolar disorder to facilitate studies on prevention

Journal of Clinical Psychiatry

Volumn 74, Issue 2, 2013, Pages 167-169

  Post, Robert M ^a   Chang, Kiki ^b   Frye, Mark A ^c  

^a Bipolar Collaborative Network   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM; LITHIUM CARBONATE; OLANZAPINE; OMEGA 3 FATTY ACID; PROLACTIN; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VITAMIN;

ALCOHOLISM; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CHILD; CHILDHOOD DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DRUG TOLERABILITY; EARLY INTERVENTION; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; MANIA; MORBIDITY; NEUROBIOLOGY; NOTE; ONSET AGE; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHOTHERAPY; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY PREVENTION; SEDATION; SIDE EFFECT; SUBSTANCE ABUSE; TREATMENT RESPONSE; WEIGHT GAIN;

EID: 84874595075     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12com08136     Document Type: Note

References (48)

1. Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative. Arch Gen Psychiatry. 2011;68(3):241-251.
2. Merikangas KR, He JP, Burstein M, et al. Service utilization for lifetime mental disorders in US adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2011;50(1):32-45.
3. Post RM, Leverich GS, Kupka RW, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry. 2010;71(7):864-872.
4. Perlis RH, Miyahara S, Marangell LB, et al, and the STEP-BD Investigators. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry. 2004;55(9):875-881. (Pubitemid 38526299)
5. Birmaher B, Axelson D. Course and outcome of bipolar spectrum disorder in children and adolescents: a review of the existing literature. Dev Psychopathol. 2006;18(4):1023-1035. (Pubitemid 46389728)
6. Birmaher B, Axelson D, Goldstein B, et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry. 2009;166(7): 795-804.
7. Birmaher B, Axelson D, Strober M, et al. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006; 63(2):175-183. (Pubitemid 43213879)
8. Birmaher B, Axelson D, Strober M, et al. Comparison of manic and depressive symptoms between children and adolescents with bipolar spectrum disorders. Bipolar Disord. 2009;11(1):52-62.
9. Birmaher B, Williamson DE, Dahl RE, et al. Clinical presentation and course of depression in youth: does onset in childhood differ from onset in adolescence? J Am Acad Child Adolesc Psychiatry. 2004;43(1):63-70. (Pubitemid 41615023)
10. Findling RL, Gracious BL, McNamara NK, et al. Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disord. 2001;3(4):202-210. (Pubitemid 32842745)
11. DelBello M, Grcevich S. Phenomenology and epidemiology of childhood psychiatric disorders that may necessitate treatment with atypical antipsychotics. J Clin Psychiatry. 2004;65(suppl 6):12-19.
12. DelBello MP. Can research inform the clinical care of mental health disorders in children and adolescents? J Clin Psychiatry. 2007;68(2):296.
13. DelBello MP, Hanseman D, Adler CM, et al. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry. 2007;164(4):582-590. (Pubitemid 46650189)
14. Geller B, Craney JL, Bolhofner K, et al. One-year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry. 2001;158(2):303-305. (Pubitemid 32116529)
15. Geller B, Craney JL, Bolhofner K, et al. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry. 2002;159(6):927-933. (Pubitemid 34586936)
16. Geller B, Tillman R, Bolhofner K, et al. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry. 2008;65(10): 1125-1133.
17. Geller B, Tillman R, Bolhofner K, et al. Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. Bipolar Disord. 2010;12(2):164-171.
18. Geller B, Tillman R, Craney JL, et al. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch Gen Psychiatry. 2004;61(5):459-467. (Pubitemid 38620844)
19. Wozniak J. Recognizing and managing bipolar disorder in children. J Clin Psychiatry. 2005;66(suppl 1):18-23. (Pubitemid 350042453)
20. Wozniak J, Petty CR, Schreck M, et al. High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: a four year prospective longitudinal follow-up study. J Psychiatr Res. 2011;45(10): 1273-1282.
21. Perlis RH, Dennehy EB, Miklowitz DJ, et al. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord. 2009;11(4):391-400.
22. Carter TD, Mundo E, Parikh SV, et al. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res. 2003;37(4):297-303. (Pubitemid 36579410)
23. Frye MA, Ketter TA, Altshuler LL, et al. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Disord. 1998;48(2-3):91-104. (Pubitemid 28244210)
24. Begley CE, Annegers JF, Swann AC, et al. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics. 2001;19(5, pt 1):483-495. (Pubitemid 32488750)
25. Kowatch RA, DelBello MP. Pharmacotherapy of children and adolescents with bipolar disorder. Psychiatr Clin North Am. 2005;28(2):385-397
26. Kowatch RA, Fristad M, Birmaher B, et al, and the Child Psychiatric Workgroup on Bipolar Disorder. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(3):213-235. (Pubitemid 40299835)
27. Kowatch RA, Youngstrom EA, Danielyan A, et al. Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar Disord. 2005;7(6):483-496. (Pubitemid 41829996)
28. Post RM, Wozniak J. Survey of expert treatment approaches for children with bipolar disorder not otherwise specified and bipolar I presentations. Psychiatr Ann. 2009;39(10):887-895.
29. Geller B, Luby JL, Joshi P, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry. 2012;69(5):515-528.
30. Youngstrom EA, Findling RL, Calabrese Jr. Effects of adolescent manic symptoms on agreement between youth, parent, and teacher ratings of behavior problems. J Affect Disord. 2004;82(suppl 1):S5-S16. (Pubitemid 39574979)
31. Youngstrom EA, Freeman AJ, Jenkins MM. The assessment of children and adolescents with bipolar disorder. Child Adolesc Psychiatr Clin N Am. 2009; 18(2):353-390.
32. Youngstrom EA, Joseph MF, Greene J. Comparing the psychometric properties of multiple teacher report instruments as predictors of bipolar disorder in children and adolescents. J Clin Psychol. 2008;64(4):382-401. (Pubitemid 351548294)
33. Frazier TW, Youngstrom EA, Horwitz SM, et al. Relationship of persistent manic symptoms to the diagnosis of pediatric bipolar spectrum disorders. J Clin Psychiatry. 2011;72(6):846-853.
34. Chang KD, Steiner H, Ketter TA. Psychiatric phenomenology of child and adolescent bipolar offspring. J Am Acad Child Adolesc Psychiatry. 2000;39(4): 453-460. (Pubitemid 30185540)
35. Lapalme M, Hodgins S, LaRoche C. Children of parents with bipolar disorder: a meta analysis of risk for mental disorders. Can J Psychiatry. 1997;42(6):623-631. (Pubitemid 27397678)
36. Brent DA, Oquendo M, Birmaher B, et al. Familial pathways to early-onset suicide attempt: risk for suicidal behavior in offspring of mood-disordered suicide attempters. Arch Gen Psychiatry. 2002;59(9):801-807 (Pubitemid 35001145)
37. Brent DA, Oquendo M, Birmaher B, et al. Peripubertal suicide attempts in offspring of suicide attempters with siblings concordant for suicidal behavior. Am J Psychiatry. 2003;160(8):1486-1493 (Pubitemid 41070925)
38. Brent DA, Oquendo M, Birmaher B, et al. Familial transmission of mood disorders: convergence and divergence with transmission of suicidal behavior. J Am Acad Child Adolesc Psychiatry. 2004;43(10):1259-1266 (Pubitemid 39281666)
39. Nosarti C, Reichenberg A, Murray RM, et al. Preterm birth and psychiatric disorders in young adult life. Arch Gen Psychiatry. 2012;69(6):e1-e8
40. Leverich GS, McElroy SL, Suppes T, et al. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry. 2002; 51(4):288-297 (Pubitemid 34214994)
41. Post RM, Miklowitz DJ. The role of stress in the onset, course, and progression of bipolar illness and its comorbidites: implications for therapeutics. In: Miklowitz DJ, and Cicchetti D, eds. Understanding Bipolar Disorder: A Developmental Psychopathology Perspective. New York, New York: Guilford Press; 2010: 370-413.
42. Shonkoff JP, Garner AS, the Committee on Psychosocial Aspects of Child and Family Health, et al, and the Section on Developmental and Behavioral Pediatrics. The lifelong effects of early childhood adversity and toxic stress. Pediatrics. 2012;129(1):e232-e246
43. Post RM, Leverich GS, Fergus E, et al. Parental attitudes towards early intervention in children at high risk for affective disorders. J Affect Disord. 2002;70(2):117-124 (Pubitemid 34765553)
44. March J, Kraemer HC, Trivedi M, et al. What have we learned about trial design from NIMH-funded pragmatic trials? Neuropsychopharmacology. 2010;35(13):2491-2501.
45. March JS, Silva SG, Compton S, et al. The case for practical clinical trials in psychiatry. Am J Psychiatry. 2005;162(5):836-846. (Pubitemid 40676194)
46. Post RM, Luckenbaugh DA. Unique design issues in clinical trials of patients with bipolar affective disorder. J Psychiatr Res. 2003;37(1):61-73. (Pubitemid 35449772)
47. Stroup TS. What can large simple trials do for psychiatry? Am J Psychiatry. 2011;168(2):117-119
48. Post RM. Special issues of research methodology in bipolar clinical treatment trials. In: Hertzman M, Alder L, eds. Clinical Trials in Psychopharmacology: A Better Brain, Second Edition. Chichester, United Kingdom: Wiley-Blackwell Publishing; 2010:149-177.